{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:29:00Z","timestamp":1773001740782,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biologicals.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T22:41:31Z","timestamp":1533595291000},"page":"1-16","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Report of the international conference on next generation sequencing for adventitious virus detection in biologicals"],"prefix":"10.1016","volume":"55","author":[{"given":"Arifa S.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Blumel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Deforce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Minor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Neels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2018.08.002_bib1","series-title":"Emerging methods for virus detection","first-page":"71","author":"Khan","year":"2015"},{"key":"10.1016\/j.biologicals.2018.08.002_bib2","first-page":"374","article-title":"Introduction: PDA cell substrate workshop proceedings","volume":"64","author":"King","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib3","first-page":"492","article-title":"Synthesis session","volume":"64","author":"Wiebe","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biologicals.2012.02.001","article-title":"Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MD","volume":"40","author":"Sheets","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5731\/pdajpst.2012.00895","article-title":"PDA\/FDA adventitious agents and novel cell substrates: emerging technologies and new challenges, nov. 3-4, 2011, Rockville, MD","volume":"66","author":"Khan","year":"2012","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib6","series-title":"FDA briefing document: vaccines and related biological products advisory committee meeting: cell lines derived from human tumors for vaccine manufacture","author":"US Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.biologicals.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5731\/pdajpst.2014.01028","article-title":"Introduction and workshop summary: advanced technologies for virus detection in the evaluation of biologicals-applications and challenges","volume":"68","author":"Khan","year":"2014","journal-title":"PDA J Pharm Sci Technol"},{"issue":"6","key":"10.1016\/j.biologicals.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5731\/pdajpst.2016.007161","article-title":"Advanced virus detection technologies interest group (AVDTIG): efforts for high throughput sequencing (HTS) for virus detection","volume":"70","author":"Khan","year":"2016","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib9","series-title":"Characterizatoin and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications","author":"5 Guidance for Industry","year":"2010"},{"key":"10.1016\/j.biologicals.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02690-09","article-title":"Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus","volume":"84","author":"Victoria","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1128\/JVI.00780-14","article-title":"Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines","volume":"88","author":"Ma","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00307-17","article-title":"A multicenter study to evaluate the performance of high-throughput sequencing for virus detection","volume":"2","author":"Khan","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.biologicals.2018.08.002_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00069-18","article-title":"A reference viral database (RVDB) to enhance bioinformatics analysis of high-throughput sequencing for novel virus detection","volume":"3","author":"Goodacre","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.biologicals.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biologicals.2014.07.003","article-title":"Adventitious agents in viral vaccines: lessons learned from 4 case studies","volume":"42","author":"Petricciani","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.08.002_bib15","series-title":"Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for hte characterization of cell banks","author":"WHO Expert Committee on Biological Standardization","year":"2010"},{"key":"10.1016\/j.biologicals.2018.08.002_bib16","volume":"993","author":"WHO Expert Committee on Biologoical Strandardization","year":"2015"},{"key":"10.1016\/j.biologicals.2018.08.002_bib17","series-title":"Vaccines for human use, monograph no 153. European pharmacopoeia","author":"European Pharmacopoeia","year":"2017"},{"key":"10.1016\/j.biologicals.2018.08.002_bib18","series-title":"EMA Guideline on the principles of regulatory acceptance of 3Rs (Replacement R, Refinement) testing approaches (EMA\/CHMP\/CVMP\/JEG-3Rs\/450091\/2012)","year":"2016"},{"key":"10.1016\/j.biologicals.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.vaccine.2014.02.021","article-title":"Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products","volume":"32","author":"Gombold","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.08.002_bib20","series-title":"Vaccine analysis: strategies, principles, and control","author":"Sheets","year":"2015"},{"key":"10.1016\/j.biologicals.2018.08.002_bib21","series-title":"General chapter 5.2.14 Substitution of in vivo methods by in vitro methods for the quality control of vaccines. European pharmacopoeia","author":"European Pharmacopoeia","year":"2017"},{"key":"10.1016\/j.biologicals.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1128\/JVI.01628-12","article-title":"Complete genome sequence of Ikoma lyssavirus","volume":"86","author":"Marston","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00454-13","article-title":"Louping ill virus genome sequence derived from the spinal cord of an infected lamb","volume":"1","author":"Marston","year":"2013","journal-title":"Genome Announc"},{"key":"10.1016\/j.biologicals.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1099\/jgv.0.000440","article-title":"Discovery of hantavirus circulating among Rattus rattus in French Mayotte island, Indian Ocean","volume":"97","author":"Filippone","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4161\/hv.7.7.15683","article-title":"Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain","volume":"7","author":"Bouzon Alejandro","year":"2011","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.biologicals.2018.08.002_bib26","series-title":"Guideline on the use of porcine trypsin used in the manufacture of human biological medicinal products","author":"European Medicines Agency","year":"2014"},{"key":"10.1016\/j.biologicals.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.vaccine.2015.12.020","article-title":"Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing","volume":"34","author":"Mee","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.08.002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160334","article-title":"MetLab: an in silico experimental design, simulation and analysis tool for viral metagenomics studies","volume":"11","author":"Norling","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2018.08.002_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151481","article-title":"The intestinal eukaryotic virome in healthy and diarrhoeic neonatal piglets","volume":"11","author":"Karlsson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3201\/eid2302.161564","article-title":"Cutavirus in cutaneous malignant melanoma","volume":"23","author":"Mollerup","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biologicals.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/JVI.00064-15","article-title":"A metagenomics and case-control study to identify viruses associated with bovine respiratory disease","volume":"89","author":"Ng","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/JCM.01195-14","article-title":"Neurotropic astrovirus in cattle with nonsuppurative encephalitis in Europe","volume":"52","author":"Bouzalas","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.5","article-title":"Identification of a second encephalitis-associated astrovirus in cattle","volume":"5","author":"Seuberlich","year":"2016","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.biologicals.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0192623317723541","article-title":"A naturally transmitted epitheliotropic polyomavirus pathogenic in immunodeficient rats: characterization, transmission, and preliminary epidemiologic studies","volume":"45","author":"Besch-Williford","year":"2017","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/JVI.02989-13","article-title":"Global bidirectional transcription of the Epstein-Barr virus genome during reactivation","volume":"88","author":"O'Grady","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.5731\/pdajpst.2011.00842","article-title":"Use of DOP-PCR in non-specific virus detection","volume":"65","author":"Uhlenhaut","year":"2011","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jcv.2009.01.011","article-title":"Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin","volume":"44","author":"Uhlenhaut","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.biologicals.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biologicals.2013.11.002","article-title":"Optimization of virus detection in cells using massively parallel sequencing","volume":"42","author":"McClenahan","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1016\/j.vaccine.2014.10.022","article-title":"Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing","volume":"32","author":"McClenahan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.5731\/pdajpst.2014.01023","article-title":"Cataloguing the taxonomic origins of sequences from a heterogeneous sample using phylogenomics: applications in adventitious agent detection","volume":"68","author":"Charlebois","year":"2014","journal-title":"PDA J Pharm Sci Technol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T15:12:30Z","timestamp":1536333150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618302173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"alternative-id":["S1045105618302173"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.08.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}